Intervention group (n = 30) | Control group (n = 30) | ||||||
---|---|---|---|---|---|---|---|
OMED | n | Mean | SD | n | Mean | SD | p-value |
Baseline (t0) | 30 | 56.8 | 132.2 | 30 | 45.0 | 86.2 | 0.841 |
RT completed (t1) | 30 | 43.8 | 88.7 | 30 | 50.7 | 88.7 | 0.452 |
After 3 months (t2) | 22 | 30.2 | 59.1 | 21 | 62.7 | 84.6 | 0.091 |
After 6 months (t3) | 18 | 20.8 | 46.9 | 18 | 76.7 | 103.6 | 0.018 |
Visual analog scale | |||||||
Baseline (t0) | 30 | 48.2 | 20.5 | 30 | 51.3 | 26.9 | 0.393 |
RT completed (t1) | 30 | 23.8 | 20.2 | 30 | 33.3 | 24.6 | 0.118 |
After 3 months (t2) | 22 | 15.8 | 12.1 | 21 | 40.7 | 21.7 | <0.001 |
After 6 months (t3) | 18 | 16.7 | 14.8 | 18 | 50.3 | 22.8 | <0.001 |
Neuropathic pain | |||||||
Baseline (t0) | 30 | 0.2 | 0.4 | 30 | 0.2 | 0.4 | 0.749 |
RT completed (t1) | 30 | 0.1 | 0.3 | 30 | 0.2 | 0.4 | 0.326 |
After 3 months (t2) | 22 | 0.2 | 0.4 | 21 | 0.2 | 0.4 | 0.619 |
After 6 months (t3) | 18 | 0.2 | 0.4 | 18 | 0.2 | 0.4 | 0.694 |